Examination of Rectal Blood Supply During Rectal Cancer Surgery Using Laser Speckle Contrast Imaging
NCT: NCT07799740 · NOT_YET_RECRUITING
Brief Summary
This multicentre feasibility study evaluates the feasibility of performing laparoscopic Laser Speckle Contrast Imaging (LSCI) measurements of rectal perfusion during rectal cancer surgery. To our knowledge, LSCI has not previously been applied laparoscopically for intraoperative assessment of rectal perfusion in this setting. Laparoscopic LSCI measurements will be compared with indocyanine green fluorescence imaging, and associations between quantitative measures of colorectal perfusion and postoperative outcomes, including anastomotic leakage, will be explored.
Frequently Asked Questions
What is Examination of Rectal Blood Supply During Rectal Cancer Surgery Using Laser Speckle Contrast Imaging?
Examination of Rectal Blood Supply During Rectal Cancer Surgery Using Laser Speckle Contrast Imaging is a clinical trial registered under NCT07799740. Current status: NOT_YET_RECRUITING.
What is the status of NCT07799740?
The current status of NCT07799740 (Examination of Rectal Blood Supply During Rectal Cancer Surgery Using Laser Speckle Contrast Imaging) is: NOT_YET_RECRUITING.
When did Examination of Rectal Blood Supply During Rectal Cancer Surgery Using Laser Speckle Contrast Imaging start?
Examination of Rectal Blood Supply During Rectal Cancer Surgery Using Laser Speckle Contrast Imaging started on 2026-09-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.